From: Transition from intravenous to enteral ketamine for treatment of nonconvulsive status epilepticus
Day | Continuous EEG | Clinical features | GCS | IV ketamine, mg/kg/h | Oral ketamine, mg BID |
---|---|---|---|---|---|
1 | 1. 9 generalized electroclinical and subclinical seizures 2. Generalized slowing mixed delta and theta frequencies | Slightly confused | 14 | 1.25 | Not started yet |
2 | 1. Diffuse frontal intermittent rhythmic delta activity 2. Diffuse amplitude suppression that was bihemispheric and occasional localized slowing in the left frontal and right occipital regions 3. No epileptiform activity or nonconvulsive status was noted during this portion of the record. | Alert and oriented | 15 | Weaned off from 1.25 to 0.75 | 50 |
3 | 1. Diffuse slowing and loss of the posterior-dominant rhythm, monorhythmic frontal delta activity 2. Occasional sharp waves emanating from the right frontal and paracentral region | Alert and oriented | 15 | 0.75 | 100 |
4 | Same as day 3, with decreased frequency of sharp waves in the frontal region | Alert and oriented | 15 | Weaned off from 0.75 to 0.5 | 200 |
5 | Discontinued | Alert and oriented | 15 | Stopped | 250 |